| NCT06022276 |
Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors |
View |
| NCT06206876 |
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma |
View |
| NCT00057876 |
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer |
View |
| NCT00837876 |
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery |
View |
| NCT00316420 |
Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer |
View |
| NCT01266720 |
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) |
View |
| NCT01846520 |
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers |
View |
| NCT00564720 |
Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer |
View |
| NCT03481920 |
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer |
View |
| NCT00359320 |
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy |
View |
| NCT03375320 |
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors |
View |
| NCT01781520 |
Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer |
View |
| NCT01116791 |
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer |
View |
| NCT01111591 |
Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer |
View |
| NCT03214991 |
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer |
View |
| NCT06411691 |
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer |
View |
| NCT06151691 |
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach |
View |
| NCT03685591 |
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors |
View |
| NCT06396091 |
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer |
View |
| NCT02591082 |
Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCathâ„¢ RC120 Catheter |
View |
| NCT00012220 |
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas |
View |
| NCT05841420 |
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer |
View |
| NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
View |
| NCT06947382 |
Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer |
View |
| NCT00955773 |
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects |
View |
